We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Report South-Eastern Asia - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

South-Eastern Asia - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

South-Eastern Asia: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in South-Eastern Asia

After three years of decline, the Southeast Asian medicaments containing insulin market increased by 29% to $X in 2021. Overall, consumption, however, showed a deep contraction. Over the period under review, the market hit record highs at $X in 2013; however, from 2014 to 2021, consumption remained at a lower figure.

Medicaments Containing Insulin Production in South-Eastern Asia

In value terms, medicaments containing insulin production shrank slightly to $X in 2021 estimated in export price. In general, production, however, showed a abrupt curtailment. The most prominent rate of growth was recorded in 2013 with an increase of 28% against the previous year. As a result, production reached the peak level of $X. From 2014 to 2021, production growth remained at a lower figure.

Medicaments Containing Insulin Exports

Exports in South-Eastern Asia

After five years of growth, shipments abroad of medicaments containing insulin but not antibiotics decreased by -33.1% to X tons in 2021. Overall, exports, however, continue to indicate a significant expansion. The most prominent rate of growth was recorded in 2016 with an increase of 181% against the previous year. Over the period under review, the exports attained the peak figure at X tons in 2020, and then declined significantly in the following year.

In value terms, medicaments containing insulin exports declined dramatically to $X in 2021. In general, exports, however, showed a significant expansion. The pace of growth appeared the most rapid in 2016 when exports increased by 584%. Over the period under review, the exports reached the peak figure at $X in 2020, and then reduced notably in the following year.

Exports by Country

In 2021, Thailand (X tons) represented the major exporter of medicaments containing insulin but not antibiotics in South-Eastern Asia, making up 100% of total export.

Thailand was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics exports, with a CAGR of +102.4% from 2012 to 2021. While the share of Thailand (+93 p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Thailand ($X) also remains the largest medicaments containing insulin supplier in South-Eastern Asia.

In Thailand, medicaments containing insulin exports increased at an average annual rate of +48.3% over the period from 2012-2021.

Export Prices by Country

The export price in South-Eastern Asia stood at $X per ton in 2021, approximately mirroring the previous year. In general, the export price continues to indicate a abrupt decline. The most prominent rate of growth was recorded in 2016 when the export price increased by 143% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2017 to 2021, the export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for Thailand.

From 2012 to 2021, the rate of growth in terms of prices for Thailand amounted to -26.8% per year.

Medicaments Containing Insulin Imports

Imports in South-Eastern Asia

Medicaments containing insulin imports declined to X tons in 2021, which is down by -6.9% compared with the previous year. Overall, imports showed a drastic downturn. The pace of growth appeared the most rapid in 2017 with an increase of 245% against the previous year. The volume of import peaked at X tons in 2012; however, from 2013 to 2021, imports remained at a lower figure.

In value terms, medicaments containing insulin imports fell rapidly to $X in 2021. In general, imports continue to indicate a abrupt decrease. The pace of growth was the most pronounced in 2017 when imports increased by 103% against the previous year. Over the period under review, imports hit record highs at $X in 2012; however, from 2013 to 2021, imports remained at a lower figure.

Imports by Country

Malaysia prevails in imports structure, accounting for X tons, which was approx. 95% of total imports in 2021. Myanmar (X tons) held a minor share of total imports.

Malaysia was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics imports, with a CAGR of +2.0% from 2012 to 2021. Myanmar experienced a relatively flat trend pattern. Malaysia (+50 p.p.) significantly strengthened its position in terms of the total imports, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Malaysia ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in South-Eastern Asia, comprising 67% of total imports. The second position in the ranking was taken by Myanmar ($X), with a 29% share of total imports.

From 2012 to 2021, the average annual growth rate of value in Malaysia totaled +4.2%.

Import Prices by Country

In 2021, the import price in South-Eastern Asia amounted to $X per ton, reducing by -16.1% against the previous year. Overall, the import price, however, showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2020 when the import price increased by 41%. Over the period under review, import prices attained the maximum at $X per ton in 2016; however, from 2017 to 2021, import prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Myanmar ($X per ton), while Malaysia amounted to $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Myanmar (+17.9%).

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

Brunei Darussalam remains the largest medicaments containing insulin consuming country in South-Eastern Asia, comprising approx. 64% of total volume. Moreover, medicaments containing insulin consumption in Brunei Darussalam exceeded the figures recorded by the second-largest consumer, Indonesia, fivefold. The third position in this ranking was occupied by the Philippines, with a 11% share.
The country with the largest volume of medicaments containing insulin production was Thailand, accounting for 77% of total volume. Moreover, medicaments containing insulin production in Thailand exceeded the figures recorded by the second-largest producer, Indonesia, fivefold.
In value terms, Thailand remains the largest medicaments containing insulin supplier in South-Eastern Asia, comprising 99% of total exports. The second position in the ranking was occupied by Indonesia, with a 0.8% share of total exports.
In value terms, Brunei Darussalam, Myanmar and Indonesia were the countries with the highest levels of imports in 2020, together accounting for 87% of total imports.
In 2020, the medicaments containing insulin export price in South-Eastern Asia amounted to $9,488 per ton, surging by 8.3% against the previous year.
The medicaments containing insulin import price in South-Eastern Asia stood at $43,633 per ton in 2020, remaining constant against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in South-Eastern Asia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Production in South-Eastern Asia, split by region and country
  • Trade (exports and imports) in South-Eastern Asia
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY

  8. 8. IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • Brunei Darussalam
    • Cambodia
    • Indonesia
    • Malaysia
    • Myanmar
    • Philippines
    • Singapore
    • Thailand
    • Timor-Leste
    • Vietnam
    • Lao People's Democratic Republic

  12. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption, By Country, 2018–2023
    5. Production, In Physical Terms, By Country, 2012–2023
    6. Imports, In Physical Terms, By Country, 2012–2023
    7. Imports, In Value Terms, By Country, 2012–2023
    8. Import Prices, By Country Of Destination, 2012–2023
    9. Exports, In Physical Terms, By Country, 2012–2023
    10. Exports, In Value Terms, By Country, 2012–2023
    11. Export Prices, By Country Of Origin, 2012–2023

  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Consumption, By Country, 2023
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2023
    18. Production, In Value Terms, 2012–2023
    19. Production, By Country, 2023
    20. Production, In Physical Terms, By Country, 2012–2023
    21. Imports, In Physical Terms, 2012–2023
    22. Imports, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, By Country, 2023
    24. Imports, In Physical Terms, By Country, 2012–2023
    25. Imports, In Value Terms, By Country, 2012–2023
    26. Import Prices, By Country, 2012–2023
    27. Exports, In Physical Terms, 2012–2023
    28. Exports, In Value Terms, 2012–2023
    29. Exports, In Physical Terms, By Country, 2023
    30. Exports, In Physical Terms, By Country, 2012–2023
    31. Exports, In Value Terms, By Country, 2012–2023
    32. Export Prices, 2012–2023

Recommended reports

Asia - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 354

This report provides an in-depth analysis of the medicaments containing insulin market in Asia.

World - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 356

This report provides an in-depth analysis of the global medicaments containing insulin market.

EU - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 238

This report provides an in-depth analysis of the medicaments containing insulin market in the EU.

U.S. - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 297

This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..

China - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 248

This report provides an in-depth analysis of the medicaments containing insulin market in China.

Free Data: Medicaments Containing Insulin But Not Antibiotics - South-Eastern Asia
Table
Medicaments Containing Insulin But Not Antibiotics - South-Eastern Asia - Table
Dashboard
Medicaments Containing Insulin But Not Antibiotics - South-Eastern Asia - Dashboard
Report
Medicaments Containing Insulin But Not Antibiotics - South-Eastern Asia - Report